Civic Intelligence

Rare Cancer Research Foundation

EIN 46-3405526 • 501(c)3 • Durham, NC

Profile

The rare cancer research foundation is dedicated to curing rare cancers through strategic investments and collaborations that catalyze effective research and accelerate deployment of promising therapies.

112 S Duke Street Suite 101Durham, NC 27701

www.rcrf.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

70th percentile

0.24x

Higher debt load relative to assets than 70% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

79th percentile

0.42x

Higher debt load relative to revenue than 79% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

12th percentile

-26%

Higher net margin than 12% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

89th percentile

$194,903

Higher top officer pay than 89% of similar nonprofits.

Top officer pay equals 11.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

42nd percentile

0.8%

Faster asset growth than 42% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

6th percentile

-49%

Faster revenue growth than 6% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets70th percentile

Assets

Up

$3,059,554

Up $25,664 (+0.8%) from 2023

Liabilities

Down

$743,703

Down $198,430 (-21%) from 2023

Net Assets

Up

$2,315,851

Up $224,094 (+11%) from 2023

Operations
Liabilities / Revenue79th percentileNet Margin12th percentile

Revenue

Down

$1,773,373

Down $1,730,587 (-49%) from 2023

Expenses

Up

$2,240,471

Up $72,852 (+3.4%) from 2023

Net Income

Down

-$467,098

Down $1,803,439 (-135%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth42nd percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$4.0M$3.0M$2.0M$1.0M$0Assets 2014: $1,036,799Liabilities 2014: $0Net Assets 2014: $1,036,7992014Assets 2015: $916,404Liabilities 2015: $500Net Assets 2015: $915,9042015Assets 2016: $402,149Liabilities 2016: $11,105Net Assets 2016: $391,0442016Assets 2017: $61,752Liabilities 2017: $5,715Net Assets 2017: $56,0372017Assets 2018: $194,013Liabilities 2018: $2,021Net Assets 2018: $191,9922018Assets 2019: $261,753Liabilities 2019: $223Net Assets 2019: $261,5302019Assets 2020: $158,432Liabilities 2020: $691Net Assets 2020: $157,7412020Assets 2021: $1,051,579Liabilities 2021: $0Net Assets 2021: $1,051,5792021Assets 2022: $757,505Liabilities 2022: $2,089Net Assets 2022: $755,4162022Assets 2023: $3,033,890Liabilities 2023: $942,133Net Assets 2023: $2,091,7572023Assets 2024: $3,059,554Liabilities 2024: $743,703Net Assets 2024: $2,315,8512024

Highlighted filing

2024

Assets$3,059,554
Liabilities$743,703
Net Assets$2,315,851
Open 2024 Filing

Operations Trend

Revenue Growth6th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0M$2.0M$0-$2.0MRevenue 2014: $1,243,120Expenses 2014: $206,321Net Income 2014: $1,036,7992014Revenue 2015: $197,569Expenses 2015: $318,444Net Income 2015: -$120,8752015Revenue 2016: $6,964Expenses 2016: $531,824Net Income 2016: -$524,8602016Revenue 2017: $215,976Expenses 2017: $550,983Net Income 2017: -$335,0072017Revenue 2018: $347,745Expenses 2018: $211,790Net Income 2018: $135,9552018Revenue 2019: $316,401Expenses 2019: $246,863Net Income 2019: $69,5382019Revenue 2020: $79,640Expenses 2020: $183,429Net Income 2020: -$103,7892020Revenue 2021: $1,072,853Expenses 2021: $179,015Net Income 2021: $893,8382021Revenue 2022: $37,638Expenses 2022: $333,801Net Income 2022: -$296,1632022Revenue 2023: $3,503,960Expenses 2023: $2,167,619Net Income 2023: $1,336,3412023Revenue 2024: $1,773,373Expenses 2024: $2,240,471Net Income 2024: -$467,0982024

Highlighted filing

2024

Revenue$1,773,373
Expenses$2,240,471
Net Income-$467,098
Open 2024 Filing

Filings

Most recent year

2024 • Form 990XML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$3,059,554
Liabilities
$743,703
Net assets
$2,315,851
Revenue
$1,773,373
Expenses
$2,240,471
Net income
-$467,098
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$3.06$0.74$2.32$1.77$2.24$0.47
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$3.03$0.94$2.09$3.50$2.17$1.34
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.76$0.00$0.76$0.04$0.33$0.30
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.05$0.00$1.05$1.07$0.18$0.89
2020Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.16$0.00$0.16$0.08$0.18$0.10
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.26$0.00$0.26$0.32$0.25$0.07
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.19$0.00$0.19$0.35$0.21$0.14
2017Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.06$0.01$0.06$0.22$0.55$0.34
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.40$0.01$0.39$0.01$0.53$0.52
2015Detailed filing. Detailed filing data is available for this year.$0.92$0.00$0.92$0.20$0.32$0.12
2014Detailed filing. Detailed filing data is available for this year.$1.04$0.00$1.04$1.24$0.21$1.04
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2020 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Nov 10, 2021
Return Version
2020v4.0
Gross Receipts
$79,640
Mission and Program Overview

Mission

The rare cancer research foundation is dedicated to curing rare cancers through strategic investments and collaborations that catalyze effective research and accelerate deployment of promising therapies.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$261,753$158,432▼ $103,321
Total Assets$261,753$158,432▼ $103,321
Liabilities
Accounts Payable and Accrued Expenses-$471-
Other Liabilities$223$220▼ $3
Total Liabilities$223$691▲ $468
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$261,530$157,741▼ $103,789
Total Net Assets Fund Balance$261,530$157,741▼ $103,789
Total Liabilities and Net Assets / Fund Balance$261,753$158,432▼ $103,321
Compensation and Service Providers
Top Officer Pay89th percentile

Board Members and Trustees

NameTitle
Jyri EngestromDirector
Benjamin AbramDirector & T
Mark LaabsFounder & Ch
Revenue and Support

Revenue Composition

Contributions and Grants
$23,945
Program Service Revenue
$49,019
Investment Income
$0
Other Revenue
$6,676
All Other Contributions
$23,945
Change in Net Assets
$-103,789
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$118,889
Salaries, Compensation, and Employee Benefits$64,540
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Other$98,941--$98,941
Other Salaries and Wages$60,000--$60,000
Information Technology$9,701--$9,701
Fees for Services Accounting$4,735--$4,735
Payroll Taxes$4,540--$4,540
Office Expenses$1,376$349-$1,725
Insurance$1,445--$1,445
Travel$1,173--$1,173
Other Expenses$869--$869
Advertising$300--$300
Total Functional Expenses$183,080$349$0$183,429
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Payroll Liabilities$220
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“The form 990 "review process" will involve e-mail circulation and inspection by each of the board members followed by documented approval.”

Form 990, Page 6, Part VI, Line 12C

“To ensure the corporation operates in a manner consistent with charitable purposes and does not engage in activities that could jeopardize its tax- exempt status, periodic review shall be conducted. The periodic reviews shall, at a minimum, include whether compensation arrangements and benefits are reasonable, based on competent survey information, and the result of arm's length bargaining, and whether partnerships, joint ventures, and arrangements with management organizations conform to the corporation's written policies, are properly recorded, reflect reasonable investment or payments for goods and services, further charitable purposes and do not result in inurement, impermissible private benefit or in an excess benefit transaction.”

Form 990, Page 6, Part VI, Line 15A

“No executive officers were compensated in the current year.”

Form 990, Page 6, Part VI, Line 15B

“No executive officers were compensated in the current year.”

Form 990, Page 6, Part VI, Line 19

“All documents are currently available to the public upon request. Prospectively, all information will also be available on www.guidestar.com.”

Filing and Contact Details

Filer

Filer Name
Rare Cancer Research Foundation
EIN
46-3405526
Phone
9198278373
Address
112 S DUKE STREET SUITE 101, DURHAM, NC 27701

Signing Officer

Name
Mark Laabs
Title
Founder & Chairman
Phone
9198278373
Signed
2021-11-10
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Mark Laabs
Formed
2013
Legal Domicile
Nc
Voting Board Members
3
Independent Board Members
0
Employees
1

Preparer

Firm
Langdon & Company Llp
Address
223 US HIGHWAY 70 EAST SUITE 100, GARNER, NC 27529-4051
Preparer
Susan Dean
Phone
9196621001
Supplemental Narrative

Additional Explanations

Form 990, Part IX, Line 11G

“Contract labor 50,000 0 0 consulting services 21,749 0 0 tissue collection 25,763 0 0 regulatory fees 1,429 0 0 total 98,941 0 0”

Raw XML Appendix307 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0471
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0THE RARE CANCER RESEARCH FOUNDATION IS DEDICATED TO CURING RARE CANCERS THROUGH STRATEGIC INVESTMENTS AND COLLABORATIONS THAT CATALYZE EFFECTIVE RESEARCH AND ACCELERATE DEPLOYMENT OF PROMISING THERAPIES.
IRS990/AdvertisingGrp/ProgramServicesAmt0300
IRS990/AdvertisingGrp/TotalAmt0300
IRS990/AllOtherContributionsAmt023945
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0BARBARA VAN HARE
IRS990/BooksInCareOfDetail/PhoneNum08168686352
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt081 OLD HICKORY TRAIL
IRS990/BooksInCareOfDetail/USAddress/CityNm0HENDERSONVILLE
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NC
IRS990/BooksInCareOfDetail/USAddress/ZIPCd028739
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0261753
IRS990/CashNonInterestBearingGrp/EOYAmt0158432
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0true
IRS990/CompensationProcessOtherInd0true
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt023945
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0118889
IRS990/CYOtherRevenueAmt06676
IRS990/CYProgramServiceRevenueAmt049019
IRS990/CYRevenuesLessExpensesAmt0-103789
IRS990/CYSalariesCompEmpBnftPaidAmt064540
IRS990/CYTotalExpensesAmt0183429
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt079640
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0PATTERN.ORG IS A GROUNDBREAKING PLATFORM THAT ALLOWS RCRF TO WORK DIRECTLY WITH CANCER PATIENTS ACROSS THE COUNTRY TO IDENTIFY PATIENTS ELIGIBLE TO DONATE TISSUE TO RESEARCH, EDUCATE THOSE PATIENTS ON RESEARCH OPPORTUNITIES, CONSENT THEM INTO SUCH RESEARCH PROGRAMS, AND THEN COORDINATE THE BIO-LOGISTICS OF MOVING THEIR TISSUE FROM THEIR LOCAL HOSPITALS TO WORLD-CLASS RESEARCH INSTITUTIONS. PATTERN.ORG WAS LAUNCHED WITH GREAT SUCCESS IN 2016, AND IN 2020, IN SPITE OF THE COVID-19 PANDEMIC SUCCESSFULLY DELIVERED HIGH QUALITY, VIABLE, LIVING RARE CANCER TISSUE FROM BOTH ACADEMIC AND COMMUNITY HOSPITALS ACROSS THE U.S. TO CRITICAL, INNOVATIVE RESEARCH INITIATIVES.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt01
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0183080
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ProgramServicesAmt04735
IRS990/FeesForServicesAccountingGrp/TotalAmt04735
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt098941
IRS990/FeesForServicesOtherGrp/TotalAmt098941
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt28.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0BENJAMIN ABRAM
IRS990/Form990PartVIISectionAGrp/PersonNm1JYRI ENGESTROM
IRS990/Form990PartVIISectionAGrp/PersonNm2MARK LAABS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR & T
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2FOUNDER & CH
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02013
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt079640
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt09701
IRS990/InformationTechnologyGrp/TotalAmt09701
IRS990/InsuranceGrp/ProgramServicesAmt01445
IRS990/InsuranceGrp/TotalAmt01445
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt06
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0NC
IRS990/LoanOutstandingInd0false
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0THE RARE CANCER RESEARCH FOUNDATION IS DEDICATED TO CURING RARE CANCERS THROUGH STRATEGIC INVESTMENTS AND COLLABORATIONS THAT CATALYZE EFFECTIVE RESEARCH AND ACCELERATE DEPLOYMENT OF PROMISING THERAPIES.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0261530
IRS990/NetAssetsOrFundBalancesEOYAmt0157741
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0261530
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0157741
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0349
IRS990/OfficeExpensesGrp/ProgramServicesAmt01376
IRS990/OfficeExpensesGrp/TotalAmt01725
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherExpensesGrp/Desc0MISCELLANEOUS EXPENSES
IRS990/OtherExpensesGrp/ProgramServicesAmt0869
IRS990/OtherExpensesGrp/TotalAmt0869
IRS990/OtherLiabilitiesGrp/BOYAmt0223
IRS990/OtherLiabilitiesGrp/EOYAmt0220
IRS990/OtherRevenueMiscGrp/Desc0OTHER INCOME
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt06676
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt06676
IRS990/OtherRevenueTotalAmt06676
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt060000
IRS990/OtherSalariesAndWagesGrp/TotalAmt060000
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/ProgramServicesAmt04540
IRS990/PayrollTaxesGrp/TotalAmt04540
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0MARK LAABS
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0PROGRAM SERVICE REVENUE
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt049019
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt049019
IRS990/ProgSrvcAccomActy2Grp/Desc0IN 2020, RCRF CONTINUED TO CREATE STRATEGIC INVESTMENTS AND COLLABORATIONS THAT CATALYZED EFFECTIVE RESEARCH AND ACCELERATED THE DEPLOYMENT OF PROMISING THERAPIES.
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt038755
IRS990/PYExcessBenefitTransInd0false
IRS990/PYOtherExpensesAmt0182218
IRS990/PYProgramServiceRevenueAmt0277646
IRS990/PYRevenuesLessExpensesAmt069538
IRS990/PYSalariesCompEmpBnftPaidAmt064645
IRS990/PYTotalExpensesAmt0246863
IRS990/PYTotalRevenueAmt0316401
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0-103789
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt049019
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt023945
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt038755
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt0347745
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0215426
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt06964
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0632835
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt0333891
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.88770
IRS990ScheduleA/PublicSupportPY170Pct00.75560
IRS990ScheduleA/PublicSupportTotal170Amt0561777
IRS990ScheduleA/SubstantialContributorsTotAmt071058
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt023945
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt038755
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt0347745
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0215426
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt06964
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0632835
IRS990ScheduleA/TotalSupportAmt0632835
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0220
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0PAYROLL LIABILITIES
IRS990ScheduleD/TotalLiabilityAmt0220
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE FORM 990 "REVIEW PROCESS" WILL INVOLVE E-MAIL CIRCULATION AND INSPECTION BY EACH OF THE BOARD MEMBERS FOLLOWED BY DOCUMENTED APPROVAL.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1TO ENSURE THE CORPORATION OPERATES IN A MANNER CONSISTENT WITH CHARITABLE PURPOSES AND DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS TAX- EXEMPT STATUS, PERIODIC REVIEW SHALL BE CONDUCTED. THE PERIODIC REVIEWS SHALL, AT A MINIMUM, INCLUDE WHETHER COMPENSATION ARRANGEMENTS AND BENEFITS ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION, AND THE RESULT OF ARM'S LENGTH BARGAINING, AND WHETHER PARTNERSHIPS, JOINT VENTURES, AND ARRANGEMENTS WITH MANAGEMENT ORGANIZATIONS CONFORM TO THE CORPORATION'S WRITTEN POLICIES, ARE PROPERLY RECORDED, REFLECT REASONABLE INVESTMENT OR PAYMENTS FOR GOODS AND SERVICES, FURTHER CHARITABLE PURPOSES AND DO NOT RESULT IN INUREMENT, IMPERMISSIBLE PRIVATE BENEFIT OR IN AN EXCESS BENEFIT TRANSACTION.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2NO EXECUTIVE OFFICERS WERE COMPENSATED IN THE CURRENT YEAR.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3NO EXECUTIVE OFFICERS WERE COMPENSATED IN THE CURRENT YEAR.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4ALL DOCUMENTS ARE CURRENTLY AVAILABLE TO THE PUBLIC UPON REQUEST. PROSPECTIVELY, ALL INFORMATION WILL ALSO BE AVAILABLE ON WWW.GUIDESTAR.COM.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5CONTRACT LABOR 50,000 0 0 CONSULTING SERVICES 21,749 0 0 TISSUE COLLECTION 25,763 0 0 REGULATORY FEES 1,429 0 0 TOTAL 98,941 0 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 15A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 15B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PART IX, LINE 11G
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0false
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0261753
IRS990/TotalAssetsEOYAmt0158432
IRS990/TotalAssetsGrp/BOYAmt0261753
IRS990/TotalAssetsGrp/EOYAmt0158432
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt023945
IRS990/TotalEmployeeCnt01
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0349
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0183080
IRS990/TotalFunctionalExpensesGrp/TotalAmt0183429
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0223
IRS990/TotalLiabilitiesEOYAmt0691
IRS990/TotalLiabilitiesGrp/BOYAmt0223
IRS990/TotalLiabilitiesGrp/EOYAmt0691
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0261530
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0157741
IRS990/TotalProgramServiceExpensesAmt0183080
IRS990/TotalProgramServiceRevenueAmt049019
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt055695
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt079640
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0261753
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0158432
IRS990/TravelGrp/ProgramServicesAmt01173
IRS990/TravelGrp/TotalAmt01173
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt0703 FOSTER ST
IRS990/USAddress/CityNm0DURHAM
IRS990/USAddress/StateAbbreviationCd0NC
IRS990/USAddress/ZIPCd027701
IRS990/VotingMembersGoverningBodyCnt03
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0WWW.RCRF.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0MARK LAABS
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0FOUNDER & CHAIRMAN
ReturnHeader/BusinessOfficerGrp/PhoneNum09198278373
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-11-10
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0RARE CANCER RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0RARE
ReturnHeader/Filer/EIN0463405526
ReturnHeader/Filer/PhoneNum09198278373
ReturnHeader/Filer/USAddress/AddressLine1Txt0112 S DUKE STREET SUITE 101
ReturnHeader/Filer/USAddress/CityNm0DURHAM
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NC
ReturnHeader/Filer/USAddress/ZIPCd027701
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0561743537
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0LANGDON & COMPANY LLP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0223 US HIGHWAY 70 EAST SUITE 100
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0GARNER
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0275294051
ReturnHeader/PreparerPersonGrp/PhoneNum09196621001
ReturnHeader/PreparerPersonGrp/PreparationDt02021-11-10
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0SUSAN DEAN
ReturnHeader/ReturnTs02021-11-12T08:12:18-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0MARK
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0LAABS
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. NTEE H30 • $1M-$5M nonprofits